Corient Private Wealth LP Makes New $60.31 Million Investment in CME Group Inc. $CME

Corient Private Wealth LP purchased a new position in CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,019,758 shares of the financial services provider’s stock, valued at approximately $60,314,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Whipplewood Advisors LLC raised its position in CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after buying an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership purchased a new stake in shares of CME Group during the 4th quarter valued at about $27,000. Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of CME Group in the second quarter worth approximately $28,000. Finally, Legacy Wealth Managment LLC ID raised its holdings in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CME. UBS Group lowered their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Raymond James Financial reiterated an “outperform” rating and set a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Bank of America raised their price target on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. Barclays reduced their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Finally, Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $288.56.

Insider Activity

In other news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.0%

NASDAQ:CME opened at $280.94 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $101.02 billion, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 3.34 and a beta of 0.23. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The business has a fifty day moving average price of $253.01 and a 200-day moving average price of $279.09.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. CME Group’s quarterly revenue was up .8% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.